Table 2.
A. “Unstimulated whole saliva flow <0.1 ml/min vs ≥0.1 ml/min”
| ||||
---|---|---|---|---|
Phenotypic feature | Unadjusted OR | P value | Adjusted OR (95% CI) | P value |
Age ≥60 years | 2.04 (1.60–2.62) | <0.0001 | 2.12 (1.64–2.77) | <0.0001 |
Female gender | 2.14 (1.39–3.30) | 0.0005 | 1.92 (1.23–3.02) | 0.0043 |
Anti-SSA and/or -SSB | 0.96 (0.74–1.26) | 0.7909 | 1.35 (0.99–1.82) | 0.0513 |
Focus score≥2 | 2.59 (2.07–3.25) | <0.0001 | 2.50 (1.98–3.15) | <0.0001 |
ACA | 13.42 (5.54–44.18) | <0.0001 | 12.24 (4.91–41.02) | <0.0001 |
B. “ Schirmer’s <5 mm/5 min vs ≥5 mm/5 min”
| ||||
---|---|---|---|---|
Phenotypic feature | Unadjusted OR | P value | Adjusted OR (95% CI) | P value |
Age ≥60 years | 1.40 (1.11–1.77) | 0.0041 | 1.46 (1.14–1.86) | 0.0022 |
Female gender | 1.02 (0.66–1.58) | 0.9229 | 1.18 (0.76–1.84) | 0.4694 |
Anti-SSA and/or -SSB | 1.28 (0.98–1.66) | 0.0663 | 1.55 (1.17–2.07) | 0.0026 |
Focus score ≥2 | 2.02 (1.62–2.52) | <0.0001 | 1.97 (1.58–2.46) | <0.0001 |
ACA | 2.21 (1.37–3.66) | 0.0009 | 2.52 (1.50–4.36) | 0.0004 |
Abbreviations: ACA: anticentromere antibody